Prostate cancer (advanced hormone dependent) -degarelix depot: registration to attend the appeal
The Institute has received two appeals against the Final Appraisal Determination and Guidance on this technology. The Institute has arranged the hearing for the appeals received against the FAD for the above technology. The appeal panel will convene on 25 June 2014 to hear oral representations from the appellants.
The registration period for this appeal has now passed.
This page was last updated: 15 May 2014